VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PHGE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PHGEBiomX Inc.
$0.36$935M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPHGEQuarterly Financials

BiomX Inc. (PHGE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BiomX Inc. (PHGE) quarterly income statement — complete revenue, gross profit & net income history

PHGE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold01.15M1.24M292K00322K0229K212K219K217K223K0000819K00
COGS % of Revenue--------------------
Gross Profit0-1.15M-1.24M-292K00-322K0-229K-212K-219K-217K-223K0000-819K00
Gross Margin %--------------------
Gross Profit Growth %---285.4%-100%100%-47.03%100%-2.69%----100%------
Operating Expenses1.3M6.04M7.29M7.14M7.76M-16.68M10.21M9.72M6.56M5.06M7.58M5.86M5.99M5.56M6.55M7.32M7.79M8.97M9.83M7.3M
OpEx % of Revenue--------------------
Selling, General & Admin1.61M2.29M2.41M2.42M2.51M6.03M2.93M2.83M2.45M2.38M1.94M2.04M1.42M3.09M2.63M2.36M2.48M2.39M2.85M3.1M
SG&A % of Revenue--------------------
Research & Development-315K4.91M6.12M5.01M5.25M11.57M7.28M6.9M4.11M2.67M5.64M3.82M4.56M5.24M3.54M4.58M4.93M6.57M6.61M3.82M
R&D % of Revenue--------------------
Other Operating Expenses0-1000K-1000K-292K0-1000K0000000-1000K380K379K380K0380K380K
Operating Income-1.3M-7.2M-8.54M-7.43M-7.76M16.68M-10.53M-9.72M-6.79M-5.27M-7.79M-6.07M-6.21M-5.56M-6.55M-7.32M-7.79M-9.79M-9.83M-7.3M
Operating Margin %--------------------
Operating Income Growth %83.29%-143.12%18.91%23.57%-14.31%416.48%-35.05%-60.14%-9.29%5.18%-19.03%17.08%20.27%43.18%33.4%-0.3%8.85%-7.91%-211.36%-14.2%
EBITDA-18.95M-6.04M-7.29M-7.14M-7.52M17.61M-10.21M-9.39M-6.56M-5.06M-7.58M-5.86M-5.99M-5.31M-5.92M-6.69M-7.15M-8.97M-9.21M-6.74M
EBITDA Margin %--------------------
EBITDA Growth %-151.97%-134.32%28.52%23.98%-14.7%447.94%-34.7%-60.42%-9.54%4.7%-27.97%12.45%16.34%40.78%35.71%0.7%10.43%-0.89%-197.63%-14.58%
D&A (Non-Cash Add-back)01.15M1.24M292K236K921K322K331K229K212K219K217K223K250.25K629K635K632K819K625K566K
EBIT-18.95M-13.11M-9.16M-6M-7.65M-8.51M9.65M4.49M-14.71M-4.97M-7.32M-5.66M-5.79M-5.56M-6.22M-6.99M-7.7M-9.79M-9.85M-7.33M
Net Interest Income-569K-223K-5K-30K-810K-5K327K316K-2.62M-305K-192K-420K-238K-820K-275K-149K-374K-544K-188K-31K
Interest Income000000332K329K0215K382K325K327K-242K280K339K87K77K00
Interest Expense569K223K5K30K810K5K5K13K2.62M520K574K745K565K578K555K488K461K621K188K31K
Other Income/Expense-17.84M-6.14M-627K1.4M98K-31.2M20.17M14.2M-10.54M-218K-103K-330K-147K-287K-223K-149K-374K-621K-188K-31K
Pretax Income-19.14M-13.34M-9.16M-6.04M-7.66M-14.51M9.64M4.48M-17.32M-5.49M-7.9M-6.4M-6.36M-5.85M-6.77M-7.47M-8.16M-10.41M-10.02M-7.33M
Pretax Margin %--------------------
Income Tax01K3K2K1K3K05K5K1K8K8K6K39K8K9K9K51K10K3K
Effective Tax Rate %0%-0.01%-0.03%-0.03%-0.01%-0.02%0%0.11%-0.03%-0.02%-0.1%-0.12%-0.09%-0.67%-0.12%-0.12%-0.11%-0.49%-0.1%-0.04%
Net Income-19.14M-13.34M-9.17M-6.04M-7.66M-14.51M5.07M4.47M-17.33M-5.49M-7.91M-6.41M-6.36M-5.89M-6.78M-7.48M-8.17M-10.46M-10.03M-7.34M
Net Margin %--------------------
Net Income Growth %-149.9%8.1%-280.9%-235.03%55.8%-164.31%164.09%169.74%-172.39%6.71%-16.61%14.31%22.13%43.71%32.41%-1.99%2.77%-14.36%-13.54%-18.21%
Net Income (Continuing)-19.14M-13.34M-9.17M-6.04M-7.66M-14.51M9.64M4.47M-17.33M-5.49M-7.91M-6.41M-6.36M-5.89M-6.78M-7.48M-8.17M-10.46M-10.03M-7.34M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-7.38-12.600.29-3.61-6.27-15.205.89-13.30-528.20-22.61-24.70-22.80-38.00-37.24-43.70-47.50-51.30-69.73-70.30-57.00
EPS Growth %-17.7%17.11%-95.08%72.86%98.81%32.77%123.85%41.67%-1290%39.29%43.48%52%25.93%46.59%37.84%16.67%23.08%7.09%3.14%-11.11%
EPS (Basic)-7.38-6.76-5.55-3.61-6.27-3.995.891.90-528.20-22.61-24.70-22.80-38.00-37.24-43.70-47.50-51.30-69.73-70.30-57.00
Diluted Shares Outstanding2.6B1.63B1.65B1.65M1.22B9.57M8.63M5.66M3.28M2.42M3.19M2.71M1.69M1.58M1.57M1.57M1.57M1.5M1.43M1.28M
Basic Shares Outstanding2.6M69.81M36.74M36.74M36.74M3.67M3.67M3.67M3.28M2.42M3.19M2.71M1.69M1.58M1.57M1.57M1.57M1.5M1.43M1.28M
Dividend Payout Ratio--------------------